SSH - THE VILLAGES
1. Target Overview & Investment Thesis
SSH - THE VILLAGES is a 40-bed community hospital in SUMTER, FL with $21.8M in net patient revenue and a 3.1% operating margin. The hospital serves a payer mix of 36.5% Medicare, 0.0% Medicaid, and 63.5% commercial.
Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.1% to 10.5% (+736bps).
| Net Revenue HCRIS | $21.8M |
| Current EBITDA COMPUTED | $675K |
| Operating Margin COMPUTED | 3.1% |
| Occupancy HCRIS | 82.9% |
| Revenue / Bed COMPUTED | $544K |
| Net-to-Gross HCRIS | 21.8% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 3.1% places it below the state median. Among 78 size-comparable peers (20-80 beds), the median margin is 1.6%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (20-80), prioritizing same-state peers. 78 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SSH - THE VILLAGES (Target) | FL | 40 | $21.8M | 3.1% |
| ASCENSION SACRED HEART EMERALD | FL | 80 | $187.9M | 16.1% |
| GULF BREEZE HOSPITAL | FL | 65 | $121.8M | 12.8% |
| OVIEDO MEDICAL CENTER | FL | 64 | $110.9M | 7.4% |
| BARTOW REGIONAL MEDICAL CENTER | FL | 72 | $90.9M | 11.3% |
| BAPTIST MEDICAL CTR-NASSAU | FL | 54 | $85.1M | 2.1% |
| UCF LAKE NONA HOSPITAL | FL | 64 | $80.3M | 1.8% |
| JACKSON HOSPITAL MARIANNA | FL | 66 | $75.3M | -9.7% |
| TWIN CITIES HOSPITAL | FL | 65 | $73.6M | 39.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $457K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $435K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $431K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $265K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $14K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $675K |
| + RCM Uplift | +$1.6M |
| Pro Forma EBITDA | $2.3M |
| Current Margin | 3.1% |
| Pro Forma Margin | 10.5% |
| WC Released (1x) | $834K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.0M | $20.5M | 19.70x | 81.5% |
| Base (11x exit) | 10.0x | 11.0x | $1.0M | $22.9M | 22.00x | 85.5% |
| Bull Case | 9.0x | 11.0x | $935K | $28.5M | 30.45x | 98.0% |
| Bull (12x exit) | 9.0x | 12.0x | $935K | $31.3M | 33.51x | 101.9% |
| Bear Case | 11.0x | 10.0x | $1.1M | $12.1M | 10.61x | 60.4% |
| Bear (11x exit) | 11.0x | 11.0x | $1.1M | $13.7M | 11.99x | 64.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 78 hospitals with 20-80 beds
- Same-state prioritization (n=79)
- Comp margins: P25=-19.2% / P50=1.6% / P75=11.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.